Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

BioScrip Inc Reaffirms FY 2013 Guidance


Wednesday, 7 Aug 2013 05:17pm EDT 

BioScrip Inc announced that for fiscal 2013, it expects revenue to be in a range of $830.0 million to $865.0 million and adjusted EBITDA to be in a range of $67.0 million to $73.0 million. According to I/B/E/S Estimates, analysts are expecting the Company to report revenues of $851.5 million for fiscal 2013. 

Company Quote

6.37
 +0.00%
24 Dec 2014